News Janssen's Imbruvica runs into trouble with NICE in mantle ce... NICE suggests interim CDF funding while further data is gathered.
News New Novartis blood cancer drug approved in EU Rydapt approved in mastocytosis, related blood cancers, and AML
News FDA puts hold on AZ and Celgene immunotherapy trials Regulator is exploring safety of immunotherapy combinations in blood cancer
News FDA halts recruitment to three BMS Opdivo trials FDA is investigating safety of immunotherapies in blood cancer.
News Janssen art campaign raises awareness about blood cancer Janssen has launched a campaign to raise awareness about blood cancer, unveiling a giant art installation in London’s Paternoster Square.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
